PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Development of a reversed-phase HPLC method for analysis of fluocinolone acetonide in gel and ointment

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
An accurate and precise HPLC assay has been established for simul-taneous determination of fluocinolone acetonide and additives in gel. Drugs were chromatographed on a C18 reversed-phase column with 55:45 (v/v) methanol–water as mobile phase and detection at 238 nm. Solution con-centrations were measured on a weight basis to avoid the use of an internal standard. The method was statistically validated for linearity, accuracy, precision, and selectivity. Linearity for assay of fluocinolone acetonide, methyl 4-hydroxybenzoate (nipagin M), and propyl 4-hydroxybenzoate (nipagin P) were confirmed over the ranges 0.5-30, 5-200, and 10-120 µg mL-1, respectively. Because of the simplicity and accuracy of the method, it was used for routine analysis of fluocinolone acetonide in ointment. It does not require any specific sample preparation.
Słowa kluczowe
EN
Rocznik
Tom
Strony
80--91
Opis fizyczny
Bibliogr. 20 poz., rys., tab.
Twórcy
autor
  • Medical University of Gdańsk, Faculty of Pharmacy, Hallera 107, PL-80-416 Gdańsk, Poland
Bibliografia
  • [1] L. Amendola, F. Gabribba, and F. Botre, Anal. Chim. Acta, 489, 233 (2003)
  • [2] V. Cirimele, P. Kintz, V. Dumestre, J.P. Goulle, and B. Ludes, Forensic Sci. Int., 107, 38 (2000)
  • [3] J.J. Rivero-Marabe, J.I. Maynar-Marino, M.P. Garcia-de-Tiedra, A.M. Galan-Martin, M.J. Caballero-Loscos, and M. Maynar-Marino, J. Chromatogr. B, 761, 77 (2001)
  • [4] P. Volin, J. Chromatogr. B, 671, 319 (1995)
  • [5] K. Fluri, L. River, A. Dienes-Nagy, Ch. You, A. Maitre, C. Schweizer, M. Saugy, and P. Mangin, J. Chromatogr. A, 926, 87 (2001)
  • [6] M. Katayama, Y. Masuda, and H. Taniguchi, J. Chromatogr., 612, 33 (1993)
  • [7] P. Volin, J. Chromatogr. B, 666, 347 (1995)
  • [8] Y. Miyachi, M. Ishihara, S. Kurihara, M. Yoshida, H. Masuda, M. Komuro, K. Taira, and Y. Kawaguchi, Steroids, 52, 137 (1988)
  • [9] K. Mizoguchi, M. Yuzurihara, A. Ishige, H. Sasaki, D-H. Chui, and T. Tabira, Psychoneuroendocrinology, 26, 443 (2001)
  • [10] S.J. Park, Y.J. Kun, and H.S. Pyo, J. Anal. Toxicol., 14, 102 (1990)
  • [11] M.H. Sayed, A.L. Habet, and M.J. Rogers, J. Pharm. Sci., 78, 660 (1989)
  • [12] M. Takeda, M. Maeda, and A. Tsuji, Biomed. Chromatogr., 4, 119 (1990)
  • [13] P. Volin, J. Chromatogr., 584, 147 (1992)
  • [14] L.A. Gifford, F.T.K. Owusu-Daaku, and A.J. Stevens, J. Chromatogr. A, 715, 201 (1995)
  • [15] L. Gagliardi, D. Orsi, M.R. Giudice, F. Gatta, R. Porra, P. Chimenti, and D. Tonelli, Anal. Chim. Acta, 457, 187 (2002)
  • [16] H. Nishi, J. Chromatogr. A, 780, 243 (1997)
  • [17] M.E. Capella-Peiro, M. Gil-Agusti, L. Monferrer-Pons, and J. Esteve-Romero, Anal. Chim. Acta, 454, 125 (2002)
  • [18] J. Esteve-Romero, S. Carda-Broch, M. Gil-Augusti, M.E. Capella-Peiro, and D. Bose, Trends Anal. Chem., 24, 75 (2005)
  • [19] Farmakopea Polska VI, PTF, Warszawa, 408 (2002)
  • [20] European Pharmacopoeia, 5th edn, Council of Europe, Strasbourg, 1610 (2005)
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-BAT3-0037-0012
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.